Skip to content
logo
Pact & Health LLC
  • Home
  • Vision
  • Technologies
  • Pipeline
  • News
  • Collaborations
  • Contact Us

logo
Pact & Health LLC
  • Home
  • Vision
  • Technologies
  • Pipeline
  • News
  • Collaborations
  • Contact Us
15june22

Towards targeted-gold nanoparticle enhanced chemoradiation therapy of pancreatic cancer

Leave a Comment / News / By admin

https://aacrjournals.org/cancerres/issue/82/12_Supplement

Post navigation
← Previous Post
Next Post →

Leave a Comment Cancel Reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Systemic antitumor immune response of doped yttria nanoscintillators under low-dose x-ray irradiation
  • Towards targeted-gold nanoparticle enhanced chemoradiation therapy of pancreatic cancer
  • Gene Expression and Early Radiation Response of Two Distinct Neuroblastoma Cell Lines
  • 2-deoxy-D-glucose mitigates Citrobacter rodentium and dibenzazepine-induced gastrointestinal damage and colitis: novel implications of 2-DG polypharmacopea
  • Differential expression of deubiquitinating enzymes and its related DNA damage response genes in neuroblastoma heterogeneity
  • Technological advancements in cancer diagnostics: Improvements and limitations
  • Technological Advancements in External Beam Radiation Therapy (EBRT): An Indispensable Tool for Cancer Treatment
  • Technological advancements in brachytherapy of cancer
  • Development of radiation-triggered phosphor platform for localized activation in combinatory cancer treatment (July, 2021)
  • Inhibition of pseudo SARS-CoV-2 binding activity of a anti-cancer polypharmacological agent analogs (July, 2021)

Branford, CT, USA
inforad@pactandhealth.com

Site Menu

  • Home
  • Vision
  • Technologies
  • Pipeline
  • News
  • Collaborations
  • Contact Us
flogo-1

Copyright © 2025 Pact & Health LLC